Suchergebnisse - "Hsu, Chi-Kuei"

PubPharm (36)

1

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

enthalten in: Expert review of anti-infective therapy | 2024

von Hsu, C. | Hsu, W. | Shiau, B. | +6

2

Evaluation of three brands of Mueller-Hinton media for broth microdilution method to determine the susceptibility of multidrug-resistant Gram-negative bacilli against eravacycline

enthalten in: International journal of antimicrobial agents | 2024

von Hsu, C. | Lai, C. | Chen, C. | +2

3

Comparative outcomes of SARS-CoV-2 primary and reinfection in older adult patients

enthalten in: Frontiers in public health | 2024

von Tey, S. | Tsai, Y. | Wu, J. | +6

4

Assessing risk factors for COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease

enthalten in: Journal of medical virology | 2023

von Huang, P. | Lai, C. | Hsu, C.

CommentOn: J Med Virol. 2023 Sep;95(9):e29098. - PMID 37707416

5

Clinical efficacy and safety of interleukin-1 blockade in the treatment of patients with COVID-19 : a systematic review and meta-analysis of randomized controlled trials

enthalten in: Annals of medicine | 2023

von Lan, S. | Hsu, C. | Chang, S. | +2

6

Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections : a systematic review and meta-analysis of randomized controlled trials

enthalten in: International journal of antimicrobial agents | 2023

von Chen, T. | Hsu, C. | Shih, S. | +3

7

Ceftobiprole medocaril for the treatment of pneumonia

enthalten in: Expert review of anti-infective therapy | 2023

von Hsu, W. | Hsu, C. | Lai, C.

8

Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection : A systematic review and meta-analysis

enthalten in: Journal of global antimicrobial resistance | 2023

von Huang, P. | Hsu, C. | Liu, T. | +5

9

Cefepime/Enmetazobactam vs Piperacillin/Tazobactam and Complicated Urinary Tract Infection or Acute Pyelonephritis

enthalten in: JAMA | 2023

von Hsu, C. | Tsai, W. | Lai, C.

CommentOn: JAMA. 2022 Oct 4;328(13):1304-1314. - PMID 36194218

10

Long COVID : An inevitable sequela of SARS-CoV-2 infection

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2023

von Lai, C. | Hsu, C. | Yen, M. | +3